Immunoprecipitation Market Share, Growth, Opportunities 2031

Immunoprecipitation Market Share, Growth, Opportunities 2031

Segments - Immunoprecipitation Market by Types (Tagged Proteins, Ribonucleoprotein, Chromatin, Protein Complex, and Individual Protein), Products (Reagents [Beads, Antibodies, and Others] and Kits), End-users (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4126 | 4.4 Rating | 73 Reviews | 189 Pages | Format : PDF Excel PPT

Report Description


The Global Immunoprecipitation Market size was valued at USD 729.46 Million in 2022 and is expected to surpass USD 1.61 Billion by 2031, expanding at a CAGR of 9.2% during the forecast period, 2023 – 2031. The growth of the market is attributed to increase in research activity in the life sciences sector.

Immunoprecipitation is one of the most extensively utilized techniques in present cell biology for probing protein–protein interactions. Collaborative efforts between organizations and researchers have aided the expansion of the life science industry significantly. Academic advances in the study of cellular and genetic therapies have resulted in novel strategies for biological therapeutics. 

Immunoprecipitation Market Outlook

The scope of new discoveries is expanding as the number of research efforts in microbiome, immunotherapy, and genomics grows. With the emergence of advanced genetic tools, R&D for genomics for clinical research, medication discovery, and customized therapy design has grown steadily. Many regulatory and federal agencies are launching strategic measures to support genetic research and improve their region's healthcare system.

The cost of genomic-based research is high, necessitating increased funding. In immunoprecipitation techniques, technological developments are clearly visible. Chromatrap Immunoprecipitation (ChIP) technology developed as a result of advancements in the chromatin immunoprecipitation methodology. A bead-free approach of chromatin immunoprecipitation has been developed due to advancements in the technique, which is termed as Chromatrap Immunoprecipitation (ChIP).

  • Increasing technological advancements in immunoprecipitation method is estimated to drive the market.

  • Academic developments in the fields of cellular and genetic therapies have resulted in innovative approaches for biological therapeutics, which is projected to fuel the market.

  • Increasing number of cancer cases and the demand for precision medications is expected to boost the immunoprecipitation market during the forecast period.

  • Rising cardiovascular and orthopedic disorders, as well as the demand for precision drugs to treat them is anticipated to propel the market.

  • Growing importance of stem cell therapy in the development of cell-based treatments is one of the major factors driving the market.

  • Availability of alternate protein isolation technologies is estimated to hamper the market growth.

  • R&D investment and technological advancement in the immunoprecipitation is projected to create lucrative opportunities for the market players.

Scope of Immunoprecipitation Market Report

The report on the global immunoprecipitation market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
 

Attributes

Details

Report Title

Immunoprecipitation Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023 – 2031

Segmentation

Types (Tagged Proteins, Ribonucleoprotein, Chromatin, Protein Complex, and Individual Protein), Products (Reagents [Beads, Antibodies, and Others] and Kits), End-users (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Geno Technology Inc.; Cell Signaling Technology, Inc.; Abbkine Scientific Co., Ltd.; Rockland Immunochemicals Inc.; BioLegend; Takara Bio Inc.; Bio-Rad Laboratories; Merck KGaA; GenScript Biotech Corporation; Abcam plc; and Thermo Fisher Scientific

Immunoprecipitation Market Segment Insights

The individual protein segment accounted for a major market share in 2021

Based on types, the market is segregated into tagged proteins, ribonucleoprotein, chromatin, protein complex, and individual protein. The individual protein segment accounted for a major market share in 2021. The most typical application of immunoprecipitation, in which a specific protein is extracted, is for protein purification.

The co-immunoprecipitation, on the other hand, is linked to protein-protein interactions, in which an unknown protein is isolated from a complex solution of a known protein. The tagged proteins segment is anticipated to expand at a rapid pace during the forecast period. Due to the limitations on standard immunoprecipitation techniques, tagged protein segment has become popular. Immunoprecipitation of several proteins is impossible due to a shortage of antibodies.

Immunoprecipitation Market Types

The reagents segment held major market share in 2021

On the basis of products, the market is bifurcated into reagents and kits. The reagents segment is further divided into beads, antibodies, and others. The reagents segment held major market share in 2021 owing to frequent use of several buffers, beads, and antibodies. Researchers frequently utilize agarose beads to purify proteins.

However, since the introduction of magnetic beads, demand for them has increased, propelling the immunoprecipitation market. The kits segment is estimated to expand at a significant rate during the forecast period owing to availability of extensive product range. They include, SureBeads Starter kit, Methylated DNA Immunoprecipitation (MeDIP) kit, and Imprint Chromatin Immunoprecipitation kit.

The academic & research institutes segment dominated the market in 2021

In terms of end-users, the market is fragmented as contract research organizations, pharmaceutical & biotechnology companies, and academic & research institutes. The academic & research institutes segment dominates the market. Growth of the segment is attributed to increasing government funding for R&D activities.

Furthermore, the expansion of this segment is aided by increased collaborative efforts between organizations and academia. The contract research organizations segment is expected to expand at a high CAGR during the forecast period. Major companies are constantly outsourcing their drug development activities and research to CROs in order to increase profit margins. This is projected to drive the market during the projected period.

Immunoprecipitation Market End Users

Asia Pacific is projected to register a substantial growth during the forecast period

On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is projected to register a substantial growth during the projected period. Growth of the market in the region is attributed to rising disposable income and infrastructure development in developing countries such as India and China.

North America accounted for a major market share in 2021 owing increasing R&D spending by biotechnology and pharmaceutical companies. Furthermore, rising life science sector in the United States is enabling extensive use of immunoprecipitation techniques, hence improving protein purification procedures. Another aspect propelling the market is technological improvements in this region.

Immunoprecipitation Market Regions

Segments

The global immunoprecipitation market has been segmented on the basis of

Types

  • Tagged Proteins
  • Ribonucleoprotein
  • Chromatin
  • Protein Complex
  • Individual Protein

Products

  • Reagents
  • Beads
  • Antibodies
  • Others
  • Kits

End-users

  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

Competitive Landscape

Key players competing in the immunoprecipitation market include Geno Technology Inc.; Cell Signaling Technology, Inc.; Abbkine Scientific Co., Ltd.; Rockland Immunochemicals Inc.; BioLegend; Takara Bio Inc.; Bio-Rad Laboratories; Merck KGaA; GenScript Biotech Corporation; Abcam plc; and Thermo Fisher Scientific.

Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,

  • In 2018, Abbkine introduced Conjugated Tag Antibodies with Agarose/Magnetic Beads, allowing for a quick and easy tagged protein immunoprecipitation.

  • In April 2019, REMD Biotherapeutics Inc and GenScript Biotech Corporation have formed a strategic partnership to develop new immunotherapy medications based on bispecific antibodies.

Immunoprecipitation Market Key Players

Frequently Asked Questions

The immunoprecipitation market is projected to expand at a CAGR of around 9.2% during the forecast period, 2022 – 2030.

The immunoprecipitation market size was valued at USD 668 million in 2021.

The academic & research institutes segment dominated the market in 2021

Availability of alternate protein isolation technologies is estimated to hinder the market growth.

Bio-Rad Laboratories; Merck KGaA; GenScript Biotech Corporation; Abcam plc; and Thermo Fisher Scientific are some of the top players in the market.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunoprecipitation Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Immunoprecipitation Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Immunoprecipitation Market - Supply Chain
  4.5. Global Immunoprecipitation Market Forecast
     4.5.1. Immunoprecipitation Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Immunoprecipitation Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Immunoprecipitation Market Absolute $ Opportunity
5. Global Immunoprecipitation Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Immunoprecipitation Market Size and Volume Forecast by Types
     5.3.1. Tagged Proteins
     5.3.2. Ribonucleoprotein
     5.3.3. Chromatin
     5.3.4. Protein Complex
     5.3.5. Individual Protein
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Immunoprecipitation Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Immunoprecipitation Market Size and Volume Forecast by End Users
     6.3.1. Contract Research Organizations
     6.3.2. Pharmaceutical & Biotechnology Companies
     6.3.3. Academic & Research Institutes
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Immunoprecipitation Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Immunoprecipitation Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Immunoprecipitation Demand Share Forecast, 2019-2026
8. North America Immunoprecipitation Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Immunoprecipitation Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Immunoprecipitation Market Size and Volume Forecast by Types
     8.4.1. Tagged Proteins
     8.4.2. Ribonucleoprotein
     8.4.3. Chromatin
     8.4.4. Protein Complex
     8.4.5. Individual Protein
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Immunoprecipitation Market Size and Volume Forecast by End Users
     8.7.1. Contract Research Organizations
     8.7.2. Pharmaceutical & Biotechnology Companies
     8.7.3. Academic & Research Institutes
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Immunoprecipitation Demand Share Forecast, 2019-2026
9. Latin America Immunoprecipitation Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Immunoprecipitation Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Immunoprecipitation Market Size and Volume Forecast by Types
     9.4.1. Tagged Proteins
     9.4.2. Ribonucleoprotein
     9.4.3. Chromatin
     9.4.4. Protein Complex
     9.4.5. Individual Protein
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Immunoprecipitation Market Size and Volume Forecast by End Users
     9.7.1. Contract Research Organizations
     9.7.2. Pharmaceutical & Biotechnology Companies
     9.7.3. Academic & Research Institutes
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Immunoprecipitation Demand Share Forecast, 2019-2026
10. Europe Immunoprecipitation Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Immunoprecipitation Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Immunoprecipitation Market Size and Volume Forecast by Types
     10.4.1. Tagged Proteins
     10.4.2. Ribonucleoprotein
     10.4.3. Chromatin
     10.4.4. Protein Complex
     10.4.5. Individual Protein
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Immunoprecipitation Market Size and Volume Forecast by End Users
     10.7.1. Contract Research Organizations
     10.7.2. Pharmaceutical & Biotechnology Companies
     10.7.3. Academic & Research Institutes
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Immunoprecipitation Demand Share Forecast, 2019-2026
11. Asia Pacific Immunoprecipitation Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Types
     11.4.1. Tagged Proteins
     11.4.2. Ribonucleoprotein
     11.4.3. Chromatin
     11.4.4. Protein Complex
     11.4.5. Individual Protein
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by End Users
     11.7.1. Contract Research Organizations
     11.7.2. Pharmaceutical & Biotechnology Companies
     11.7.3. Academic & Research Institutes
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Immunoprecipitation Demand Share Forecast, 2019-2026
12. Middle East & Africa Immunoprecipitation Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Types
     12.4.1. Tagged Proteins
     12.4.2. Ribonucleoprotein
     12.4.3. Chromatin
     12.4.4. Protein Complex
     12.4.5. Individual Protein
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by End Users
     12.7.1. Contract Research Organizations
     12.7.2. Pharmaceutical & Biotechnology Companies
     12.7.3. Academic & Research Institutes
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Immunoprecipitation Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Immunoprecipitation Market: Market Share Analysis
  13.2. Immunoprecipitation Distributors and Customers
  13.3. Immunoprecipitation Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Geno Technology Inc.
     13.4.2. Cell Signaling Technology, Inc.
     13.4.3. Abbkine Scientific Co., Ltd.
     13.4.4. Rockland Immunochemicals Inc.
     13.4.5. BioLegend
     13.4.6. Takara Bio Inc.
     13.4.7. Bio-Rad Laboratories
     13.4.8. Merck

Methodology

Our Clients

Pfizer
Nestle SA
Dassault Aviation
Siemens Healthcare
sinopec
Honda Motor Co. Ltd.
General Mills
Microsoft